Safety and Performance of Dressing Adhesive on Healthy VolunteersNCT01897285
A Single Centre, Randomised, Comparative, Blinded Wear Test of Two Adhesives on the AQUACEL® Foam Adhesive Dressing
A study testing AQUACEL® foam adhesive dressing in people with Safety and Performance of Dressing Adhesive on Healthy Volunteers, run by ConvaTec Inc. at 1 site in United Kingdom.
Trial summary
AQUACEL® foam adhesive dressing is a sterile Hydrofiber® foam wound dressing consisting of a waterproof outer polyurethane film, and a multi-layered absorbent pad, having a silicone adhesive border. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Safety and Performance of Dressing Adhesive on Healthy Volunteers
- What is being tested?
- AQUACEL® foam adhesive dressing
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- May 2013to May 2013
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Provide written informed consent
- Be a healthy volunteer and be over 18 years of age
- Be willing to attend two scheduled visits for application and removal of the device and adverse event review
- Have healthy unbroken skin
Who cannot join
- Subjects with a history of sensitivity to any one of the components of the device being studied
- Female subjects who are currently pregnant or lactating
- Subjects who are not willing and able to attend the 'clinic' for the required assessments
- Subjects with excessive hair on their backs
- Subjects who have any other medical condition which, according to the investigator justifies exclusion from the study
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Global Development Centre, Deeside Industrial Park
Deeside, Flintshire, CH5 2NU
About this study
AQUACEL® foam adhesive dressing is a sterile Hydrofiber® foam wound dressing consisting of a waterproof outer polyurethane film, and a multi-layered absorbent pad, having a silicone adhesive border. The multi-layered absorbent pad contains a layer of polyurethane foam and a non-woven wound contact layer of Hydrofiber® (NaCMC). This dressing product was launched in 2012. A new source of silicone adhesive is now under assessment for this product. This Healthy Volunteer Wear test will form part of the Design Validation for this change in supplier and is required to confirm that the new Silicone Adhesive trilaminate supplier can coat the silicone adhesive to provide comparable adhesive dressing performance in terms of wear time, ease of use and with a similar safety profile in relation to the skin.
- Being tested
- AQUACEL® foam adhesive dressing
- Keywords
- Performance and safety of the AQUACEL® foam adhesive dressing
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AQUACEL® foam adhesive dressingDevice
| Study group | Role | What they receive |
|---|---|---|
| All study participants: AQUACEL® foam adhesive dressings | Experimental | Original adhesive + test adhesive Receives: Device: AQUACEL® foam adhesive dressing |
What is being measured
The primary outcome is the main question the study is designed to answer.
Product Performance (Adhesion, Conformability, Ease of Application/Removal, Adhesive Residue, Comfort During Removal, Condition of the Skin)
- Adhesion at 7 days measured by: 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor
- Conformability 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor
- Dressing Integrity 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor
- Ease of Application 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor
- Ease of Removal, 1 = Very easy 2 = Easy 3 = Difficult 4 = Very difficult
- Adhesive Residue 0 = None 1 = Minimal 2 = Moderate 3 = Considerable
- Comfort during removal 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor
- Condition of the skin This will be evaluated by the Skin Irritation Scale (Doubtful reaction/weak positive reaction/ strong positive reaction/ extreme positive reaction/irritant reaction/ negative reaction)
Measured: 7 days
Secondary outcomes (1)
Safety - the Nature and Frequency of Adverse Events
Safety will be determined by the nature and frequency of Adverse Events. Condition of the skin under and around the dressings along with the incidence of skin irritation will be assessed. The incidence and nature of all adverse events will be recorded.
Condition of the skin was evaluated by the Skin Irritation Scale. The possible responses are doubtful reaction, weak positive reaction, strong positive reaction, extreme positive reaction, irritant reaction, and negative reaction.
Measured: 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jul 2013 (estimated)
- Study startMay 2013
- Primary completionMay 2013
- Study completionMay 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Safety and Performance of Dressing Adhesive on Healthy VolunteersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- ConvaTec Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Gwen Lawrence, RGN, Principal investigator, Wirral University Teaching Hospital NHS Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01897285
- Sponsor's protocol ID
- CW-0209-13-U368
- Status last verified
- May 2016
- First submitted
- 10 May 2013
- Last updated
- 17 Jun 2016
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Jun 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Single Centre, Randomised, Comparative, Blinded Wear Test of Two Adhesives on the AQUACEL® Foam Adhesive Dressing
- ClinicalTrials.gov ID
- NCT01897285
- Acronym / sponsor ID
- CW-0209-13-U368
- Keywords
- Performance and safety of the AQUACEL® foam adhesive dressing
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- ConvaTec Inc.Industry (pharma, biotech, devices)
- Study start
- May 2013
- Primary completion
- May 2013 (actual)
- Study completion
- May 2013 (actual)
- First posted
- 11 Jul 2013 (estimated)
- Results
- Posted 15 Aug 2014
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
AQUACEL® foam adhesive dressing is a sterile Hydrofiber® foam wound dressing consisting of a waterproof outer polyurethane film, and a multi-layered absorbent pad, having a silicone adhesive border. The multi-layered absorbent pad contains a layer of polyurethane foam and a non-woven wound contact layer of Hydrofiber® (NaCMC). This dressing product was launched in 2012. A new source of silicone adhesive is now under assessment for this product. This Healthy Volunteer Wear test will form part of the Design Validation for this change in supplier and is required to confirm that the new Silicone Adhesive trilaminate supplier can coat the silicone adhesive to provide comparable adhesive dressing performance in terms of wear time, ease of use and with a similar safety profile in relation to the skin.
Study design
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- Single blind (investigator)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| All study participants: AQUACEL® foam adhesive dressings | Experimental | Device: AQUACEL® foam adhesive dressingOriginal adhesive + test adhesive |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Provide written informed consent
- Be a healthy volunteer and be over 18 years of age
- Be willing to attend two scheduled visits for application and removal of the device and adverse event review
- Have healthy unbroken skin
Key exclusion criteria (5 listed)
- Subjects with a history of sensitivity to any one of the components of the device being studied
- Female subjects who are currently pregnant or lactating
- Subjects who are not willing and able to attend the 'clinic' for the required assessments
- Subjects with excessive hair on their backs
- Subjects who have any other medical condition which, according to the investigator justifies exclusion from the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AQUACEL® foam adhesive dressing | Device | All study participants: AQUACEL® foam adhesive dressings |
Primary outcome
Product Performance (Adhesion, Conformability, Ease of Application/Removal, Adhesive Residue, Comfort During Removal, Condition of the Skin)
Time frame: 7 days
* Adhesion at 7 days measured by: 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor * Conformability 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor * Dressing Integrity 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor * Ease of Application 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor * Ease of Removal, 1 = Very easy 2 = Easy 3 = Difficult 4 = Very difficult * Adhesive Residue 0 = None 1 = Minimal 2 = Moderate 3 = Considerable * Comfort during removal 1 = Excellent 2 = Good 3 = Average 4 = Poor 5 = Very Poor * Condition of the skin This will be evaluated by the Skin Irritation Scale (Doubtful reaction/weak positive reaction/ strong positive reaction/ extreme positive reaction/irritant reaction/ negative reaction)
1 secondary outcome
Safety - the Nature and Frequency of Adverse Events
Time frame: 7 days
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jun 2016.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gwen Lawrence, RGN principal investigator
Wirral University Teaching Hospital NHS Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing AQUACEL® foam adhesive dressing in people with Safety and Performance of Dressing Adhesive on Healthy Volunteers, run by ConvaTec Inc. at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 15 Aug 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Product Performance (Adhesion, Conformability, Ease of Application/Removal, Adhesive Residue, Comfort During Removal, Condition of the Skin) (time frame: 7 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2016.